Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Incyte, Novartis agree to settle long-running Jakafi royalty dispute just before trial
Fierce Pharma
Tuesday, May 6, 2025 - 10:44am
tags:
Incyte, Novartis, Jakafi, legal
Janux commences Phase Ib studies in trial for prostate cancer treatment
Clinical Trials Arena
Tuesday, May 6, 2025 - 10:31am
tags:
Janux Therapeutics, JANX007, clinical trials, prostate cancer, metastatic castration-resistant prostate cancer
US cancels FDA bargaining session over layoffs, union says
MSN/Reuters
Tuesday, May 6, 2025 - 10:29am
tags:
Donald Trump, FDA, layoffs, unions
Are pharma’s DTC platforms actually creating engagement with patients?
Medical Marketing and Media
Tuesday, May 6, 2025 - 10:27am
tags:
DTC, patients, patient engagement, Eli Lilly, LillyDirect, Pfizer, PfizerForAll, Novo Nordisk, NovoCare
US semiconductor import probe looms over medtech industry
Medtech Dive
Tuesday, May 6, 2025 - 10:24am
tags:
Medtech, semiconducters, Section 232, tariffs
Swiss biotech sector’s R&D investment grew in 2024 despite global trends
Clinical Trials Arena
Tuesday, May 6, 2025 - 10:22am
tags:
Switzerland, biotech
Aldeyra posts one hit, one miss for twice-rejected dry eye drug, plans FDA filing
Fierce Biotech
Tuesday, May 6, 2025 - 10:21am
tags:
Aldeyra Therapeutics, clinical trials, dry eye disease, reproxalap
On tariffs and pricing, Big Pharma CEOs are waiting out the storm while planning for the worst
Pharma Voice
Tuesday, May 6, 2025 - 10:16am
tags:
Big Pharma, Pharma CEOs, drug pricing, tariffs
Lilly forges a $415m ALS alliance with UK biotech Alchemab
Pharmaphorum
Tuesday, May 6, 2025 - 10:15am
tags:
Eli Lilly, ALS, Alchemab Therapeutics
Bristol Myers charts 500-plus new layoffs in NJ following expanded cost savings drive
Fierce Pharma
Monday, May 5, 2025 - 11:09pm
tags:
Bristol Myers Squibb, layoffs, New Jersey
Cardinal Health cuts employees to offset up to $300M tariff charge
Medtech Dive
Monday, May 5, 2025 - 11:06pm
tags:
Cardinal Health, Medtech, tariffs, layoffs, Donald Trump
Vertex touts early uptake of Journavx, plots $1B+ sales trajectory for Casgevy
First Word Pharma
Monday, May 5, 2025 - 11:02pm
tags:
Vertex Pharmaceuticals, Journavx, Casgevy
19 states sue to block HHS reorganization, claiming overhaul is unconstitutional
Fierce Biotech
Monday, May 5, 2025 - 10:59pm
tags:
HHS, legal, Robert F Kennedy Jr.
PTC stock slides on new data for Huntington’s drug
BioPharma Dive
Monday, May 5, 2025 - 10:57pm
tags:
PTC Therapeutics, clinical trials, Huntington's disease, PTC518
Trump administration will defend FDA against abortion pill lawsuit, asks for dismissal
The Hill
Monday, May 5, 2025 - 10:54pm
tags:
DOJ, Donald Trump, FDA, abortion pill, mifepristone
Novo’s Wegovy inches closer to becoming first FDA-approved GLP-1 weight-loss pill
BioSpace
Monday, May 5, 2025 - 11:29am
tags:
Novo Nordisk, Wegovy, FDA, obesity, weight loss
Deerfield secures more than $600M for its next biotech venture fund
BioPharma Dive
Monday, May 5, 2025 - 11:25am
tags:
Deerfield Management, funding, biotech, venture capital
Several months after Exscientia merger, AI biotech outfit Recursion reworks pipeline
Fierce Biotech
Monday, May 5, 2025 - 11:24am
tags:
Recursion, Exscientia, artificial intelligence, drug discovery
Immutep takes immunotherapy a step further with 'impressive' survival data from Keytruda combo
Fierce Biotech
Monday, May 5, 2025 - 11:21am
tags:
IMMUTEP, immunotherapy, eftilagimod alfa, head and neck cancer, clinical trials
Capricor Therapeutics announces completion of mid-cycle review meeting with FDA on deramiocel for the treatment of Duchenne Muscular Dystrophy cardiomyopathy
Stock Titan
Monday, May 5, 2025 - 11:20am
tags:
Capricor, DMD, DMD cardiomyopathy, FDA, deramiocel

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.